Chronic uveitis in children with and without juvenile idiopathic arthritis: differences in patient characteristics

Carsten Heinz1, Anne Mingels, Christian Goebel

  • 1Department of Ophthalmology, St. Franziskus-Hospital Muenster, Muenster, Germany. carsten.heinz@uveitis-zentrum.de

Insights

Juvenile idiopathic arthritis-associated anterior uveitis (JIA-AU) presents earlier and has more complications than idiopathic anterior uveitis (IAU). Antinuclear antibody (ANA) positivity and insidious onset can help differentiate JIA-AU from IAU in children.

Area of Science:

  • Ophthalmology
  • Pediatric Rheumatology
  • Immunology

Background:

  • Anterior uveitis (AU) in children can be an early indicator of juvenile idiopathic arthritis (JIA).
  • Distinguishing JIA-associated AU from idiopathic AU (IAU) is crucial for timely diagnosis and management.
  • Early identification of JIA-associated AU can prevent long-term ocular complications.

Purpose of the Study:

  • To identify clinical factors differentiating JIA-associated AU from IAU in pediatric patients.
  • To aid in the early detection of JIA in children presenting with anterior uveitis.

Main Methods:

  • Retrospective analysis of pediatric patients with IAU and JIA-associated AU.
  • Comparison of demographics, uveitis onset, course, complications, surgical interventions, and visual acuity (BCVA).
  • Statistical analysis to determine significant differentiating factors.

Main Results:

  • JIA-associated AU occurred in 88 cases, compared to 49 cases of IAU.
  • Antinuclear antibody (ANA) positivity (88% vs. 33%), insidious onset (67% vs. 31%), and persistent uveitis (82% vs. 57%) were significantly more frequent in JIA-associated AU.
  • JIA-associated AU presented at a younger median age (5 vs. 9 years), had more frequent complications at initial presentation (79% vs. 61%), and required more surgical procedures.

Conclusions:

  • Childhood anterior uveitis associated with JIA and idiopathic AU exhibit distinct clinical courses.
  • Factors such as ANA positivity, uveitis complications, insidious onset, duration >3 months, BCVA ≤20/50, and age ≤3 years may indicate JIA-associated AU.
  • JIA-associated uveitis is characterized by earlier onset, increased complications, and a higher need for systemic immunosuppression and surgery.
Abstract

Related Concept Videos

Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...